Bank of New York Mellon Corp - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 79 filers reported holding HARVARD BIOSCIENCE INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$976,109
-20.7%
227,002
+1.2%
0.00%
Q2 2023$1,231,099
+117.9%
224,244
+66.7%
0.00%
Q1 2023$565,106
+51.6%
134,5490.0%0.00%
Q4 2022$372,701
-11.0%
134,549
-17.6%
0.00%
Q3 2022$419,000
-30.7%
163,300
-2.8%
0.00%
Q2 2022$605,000
-63.4%
168,026
-36.9%
0.00%
Q1 2022$1,653,000
-5.5%
266,314
+7.3%
0.00%
Q4 2021$1,749,000
+14.2%
248,145
+13.1%
0.00%
Q3 2021$1,531,000
-9.6%
219,323
+7.9%
0.00%
Q2 2021$1,694,000
+96.5%
203,354
+28.9%
0.00%
Q1 2021$862,000
+81.1%
157,760
+42.2%
0.00%
Q4 2020$476,000
+39.6%
110,973
-2.1%
0.00%
Q3 2020$341,000
-1.7%
113,381
+1.3%
0.00%
Q2 2020$347,000
+1019.4%
111,926
+698.0%
0.00%
Q1 2020$31,000
-27.9%
14,0260.0%0.00%
Q4 2019$43,0000.0%14,0260.0%0.00%
Q3 2019$43,000
+53.6%
14,0260.0%0.00%
Q2 2019$28,000
-94.1%
14,026
-87.2%
0.00%
Q1 2019$473,000
+34.4%
109,897
-0.7%
0.00%
Q4 2018$352,000
-34.7%
110,661
+7.8%
0.00%
Q3 2018$539,000
-15.3%
102,648
-13.6%
0.00%
Q2 2018$636,000
+201.4%
118,785
+181.7%
0.00%
Q1 2018$211,000
+75.8%
42,170
+15.9%
0.00%
Q4 2017$120,000
-13.0%
36,385
-1.2%
0.00%
Q3 2017$138,000
+46.8%
36,8300.0%0.00%
Q2 2017$94,000
-5.1%
36,830
-3.1%
0.00%
Q1 2017$99,000
-12.4%
37,990
+3.1%
0.00%
Q4 2016$113,000
+6.6%
36,830
-5.7%
0.00%
Q3 2016$106,000
-26.4%
39,058
-22.3%
0.00%
Q2 2016$144,000
-57.4%
50,252
-55.2%
0.00%
Q1 2016$338,000
-12.0%
112,172
+1.3%
0.00%
Q4 2015$384,000
-7.0%
110,684
+1.2%
0.00%
Q3 2015$413,000
-47.5%
109,393
-20.8%
0.00%
Q2 2015$787,000
+223.9%
138,104
+230.1%
0.00%
Q1 2015$243,000
+2.5%
41,8340.0%0.00%
Q4 2014$237,000
+38.6%
41,8340.0%0.00%
Q3 2014$171,000
-62.3%
41,834
-58.1%
0.00%
Q2 2014$454,000
-28.6%
99,748
-25.7%
0.00%
Q1 2014$636,000
-6.7%
134,240
-7.5%
0.00%
Q4 2013$682,000
-63.5%
145,075
-59.2%
0.00%
Q3 2013$1,870,000
+166.8%
355,246
+137.8%
0.00%
Q2 2013$701,000149,3780.00%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q1 2015
NameSharesValueWeighting ↓
Harvey Partners, LLC 790,000$2,378,0003.09%
Alambic Investment Management, L.P. 25,398$76,0000.83%
Adirondack Research & Management Inc. 190,494$573,0000.80%
Archon Capital Management LLC 881,794$2,654,0000.53%
BARD ASSOCIATES INC 1,483,610$4,465,0000.47%
DALTON GREINER HARTMAN MAHER & CO 909,977$2,739,0000.45%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 1,537,800$4,629,0000.40%
Portolan Capital Management 979,067$2,947,0000.33%
HEARTLAND ADVISORS INC 961,400$2,894,0000.25%
Granahan Investment Management 1,757,176$5,289,0000.18%
View complete list of HARVARD BIOSCIENCE INC shareholders